Literature DB >> 10333480

Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.

R Chakraborty1, D Dasgupta, S Adhya, M K Basu.   

Abstract

Antisense oligonucleotides have been considered as inhibitors of growth of intracellular parasites such as Leishmania, but only limited inhibition has been observed in vitro. We have encapsulated an antisense oligonucleotide, complementary to the Leishmania universal miniexon sequence, in cationic liposomes. Low concentrations (4 microM) of encapsulated oligonucleotides specifically reduced the amastigote burden within cultured macrophages by 80%. This result illustrates the importance of effective delivery for efficient antiparasitic activity of antisense oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333480      PMCID: PMC1220262     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Rate of degradation of [alpha]- and [beta]-oligodeoxynucleotides in Xenopus oocytes. Implications for anti-messenger strategies.

Authors:  C Cazenave; M Chevrier; T T Nguyen; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

2.  Cloning and characterization of a Leishmania gene encoding a RNA spliced leader sequence.

Authors:  S I Miller; S M Landfear; D F Wirth
Journal:  Nucleic Acids Res       Date:  1986-09-25       Impact factor: 16.971

3.  Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.

Authors:  C F Bennett; D Mirejovsky; R M Crooke; Y J Tsai; J Felgner; C N Sridhar; C J Wheeler; P L Felgner
Journal:  J Drug Target       Date:  1998       Impact factor: 5.121

4.  Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene.

Authors:  M I Cybulsky; J W Fries; A J Williams; P Sultan; R Eddy; M Byers; T Shows; M A Gimbrone; T Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

Review 5.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

6.  Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.

Authors:  C Ramazeilles; R K Mishra; S Moreau; E Pascolo; J J Toulmé
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

7.  Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.

Authors:  S Wang; R J Lee; G Cauchon; D G Gorenstein; P S Low
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

8.  An acridine-linked oligodeoxynucleotide targeted to the common 5' end of trypanosome mRNAs kills cultured parasites.

Authors:  P Verspieren; A W Cornelissen; N T Thuong; C Hélène; J J Toulmé
Journal:  Gene       Date:  1987       Impact factor: 3.688

9.  Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells.

Authors:  P Pinnaduwage; L Schmitt; L Huang
Journal:  Biochim Biophys Acta       Date:  1989-10-02

10.  Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.

Authors:  O Zelphati; J L Imbach; N Signoret; G Zon; B Rayner; L Leserman
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

View more
  6 in total

Review 1.  Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.

Authors:  O Kayser; C Olbrich; S L Croft; A F Kiderlen
Journal:  Parasitol Res       Date:  2002-12-11       Impact factor: 2.289

2.  Knockdown of LdMC1 and Hsp70 by antisense oligonucleotides causes cell-cycle defects and programmed cell death in Leishmania donovani.

Authors:  Puneet Raina; Sukhbir Kaur
Journal:  Mol Cell Biochem       Date:  2011-07-31       Impact factor: 3.396

3.  Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides.

Authors:  G Lambert; E Fattal; H Pinto-Alphandary; A Gulik; P Couvreur
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

4.  Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.

Authors:  M Mishra; J M Porter-Kelley; P K Singh; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-09-01       Impact factor: 5.858

5.  Design and evaluation of liposomal formulation of pilocarpine nitrate.

Authors:  S Rathod; S G Deshpande
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

6.  Gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct.

Authors:  F Kheirandish; M Bandehpour; N Davoudi; N Mosaffa; S Dawood; B Kazemi; A Haghighi; A Khamesipour; H Masjedi; M Mohebali; F Mahboudi
Journal:  Iran J Parasitol       Date:  2013-04       Impact factor: 1.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.